Telix subpoenaed by US regulator over cancer agents
MELBOURNE: Cancer diagnostic giant Telix Pharmaceuticals says the US Securities and Exchange Commission had issued
MELBOURNE: Cancer diagnostic giant Telix Pharmaceuticals says the US Securities and Exchange Commission had issued